mpox

Documents about mpox

• Mpox Prospective Observational Cohort Study#895366ClinicalTrials.gov
• Mpox Comprehensive Assessment for Responsive Immunisation in Emergency Outbreaks#350010ClinicalTrials.gov
• European Trial Into Mpox Infection#886758ClinicalTrials.gov
• Mpox Biology, Outcome, Transmission and Epidemiology#811952ClinicalTrials.gov
• Study of Tecovirimat for Human Mpox Virus#245589ClinicalTrials.gov
• Assessment of Immune Memory - Humoral and Cellular - in mPOX-infected Patients : an Ancillary Study of the ANRS0258s MOSAIC Cohort#966917ClinicalTrials.gov
• Cuatro años de vigilancia epidemiológica de mpox en España, 2022-2025#437470Repisalud
• Analisis epidemiológico de los casos de MPOX en España, 2026 Datos extraídos de SiViES el 04/05/2026.#206606Repisalud
• Analisis epidemiológico de los casos de MPOX en España, 2026 Datos extraídos de SiViES el 01/06/2026.#298984Repisalud
• Analisis epidemiológico de los casos de MPOX en España, 2026 Datos extraídos de SiViES el 06/07/2026#437488Repisalud
• Situación Epidemiológica de los casos de MPOX en España. Datos extraídos de SiViES el 03/08/2026.#479589Repisalud
• An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC#148562ClinicalTrials.gov
• Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part3)#909477ClinicalTrials.gov
• SungmokJung/mpox_global: Initial release#677968LSHTM Data Compass
• Mpox Paediatric and Adolescent Clinical Study#848292ClinicalTrials.gov
• Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT#332817ClinicalTrials.gov
• Mpox Clade IIb Virus Introduction into Kinshasa, Democratic Republic of the Congo, July 2025#288217HAL (France)
• Community-based sentinel surveillance for Mpox-like disease among men who have sex with men and transgender individuals in India: a cross-sectional study#311495Europe PMC
• Prospective Follow-up After MVA-BN Booster Vaccination#174953ClinicalTrials.gov
• Mpox intra-action review in the Philippines, 2025.#1001225NCBI PubMed Central
• Serological Survey in African Nonhuman Primate Species in Cameroon and the Democratic Republic of the Congo Reveals Low Overall Seroprevalence to Mpox Virus#274112HAL (France)
• Situación Epidemiológica de los casos de Viruela del Mono en España. Datos extraídos de SiViES el 08/08/2024.#437486Repisalud
• Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia#356526ClinicalTrials.gov
• Performance Evaluation of Mpox Molecular POC Diagnostics#828446ClinicalTrials.gov
• Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections#136404ClinicalTrials.gov
• Genomic characterization of the 2024/2025 Mpox outbreak in Uganda#12992bioRxiv / medRxiv
• Simulating a potential mpox outbreak: Implications for outbreak control in non-endemic settings#271994bioRxiv / medRxiv
• Development of a replication-defective mpox virus platform for fundamental and therapeutic research#326338HAL (France)
• Mpox in Africa: one year continental response outcomes and way forward.#988541NCBI PubMed Central
• Dispositional moral attribution and association avoidance: explaining chronic mpox stigma even after recovery.#317931NCBI PubMed Central
• Knowledge level regarding mpox among nurses in China: a cross-sectional study.#354921NCBI PubMed Central
• Serological differentiation between Mpox infection and vaccine-induced immunity: a mini-review.#613392NCBI PubMed Central
• Longitudinal assessment of MPXV-specific IgG avidity in patients with Mpox infection.#671317NCBI PubMed Central
• Mpox vaccine acceptance and uptake in Africa: a systematic review and meta-analysis.#186221NCBI PubMed Central
• Mapping Mpox vaccine hesitancy using an integrated machine learning and structural equation modeling approach.#645540NCBI PubMed Central
• Establishment of Contextually Appropriate Cut Offs for Orthopoxvirus Serologic Assays in an Mpox-Endemic Setting#180169bioRxiv / medRxiv
• Potent protective ability of vaccinia virus LC16 strains lacking the B5R gene#189760Kyoto University Research Information Repository
• Potent protective ability of vaccinia virus LC16 strains lacking the B5R gene#189799Kyoto University Research Information Repository
• Mpox Awareness and Infection Control Practices Among Hospital Nurses and Healthcare Workers in Bangladesh.#199220NCBI PubMed Central
• Strengthening Africa’s resilience to Mpox: Preparedness and response initiatives of the Pasteur network#288139HAL (France)
• Nationwide Mpox Genomic Surveillance Reveals Clade Ib Introductions, APOBEC3-Driven Evolution, and Terminal Deletions#456622bioRxiv / medRxiv
• Reddit Discussions During the 2022 Mpox Outbreak: Observational Analysis of Sentiment, Topics, and Audience Engagement.#308762NCBI PubMed Central
• Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC#424237ClinicalTrials.gov
• Mpox outbreak preparedness and response capacity in Nigeria's Federal Capital Territory: a mixed-methods study.#228004NCBI PubMed Central
• The Mpox contextual data specification package: a data curation toolkit to support collaborative pathogen genomic surveillance.#312733NCBI PubMed Central
• The Evolutionary Dynamics and Regional Spread of Mpox in Africa: Insights from Multi-country Genomic Surveillance#427134Europe PMC
• Mpox research coordination to effectively support response efforts in Africa: Lessons learned, challenges, and way forward.#437256NCBI PubMed Central
• Ocular mpox in Southern Nigeria during the 2022 and 2024 outbreaks: a report of two cases.#458752NCBI PubMed Central
• Epidemiology and clinical manifestation of mpox in children: Systematic review and meta-analysis.#9872PubMed
• Socio-Behavioral Drivers of Mpox Risk in Congo: A Cross-Sectional Analysis of Knowledge, Attitudes, and Practices#120087Europe PMC